Found 32 matching trials
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
PHASE1This A Three-Part Drug-Drug Interaction Study To Evaluate Effects of Casopi...
Location
GSK Investigational Site
Cyclophosphamide Drug Interaction Study In Cancer Patients
PHASE1This study is designed to evaluate the potential pharmacokinetic interactio...
Location
GSK Investigational Site
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
PHASE1This is a two period study of healthy adult subjects to characterize the ef...
Location
GSK Investigational Site
Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
PHASE1The purpose of the study is to evaluate how subjects with mild or moderate ...
Location
GSK Investigational Site
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
PHASE3This a Phase III trial designed to determine if IV casopitant plus dexameth...
Location
GSK Investigational Site
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
PHASE1GW679769 may affect liver enzymes that metabolize warfarin. This study is d...
Location
GSK Investigational Site
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
PHASE3This study is being conducted to see if adding GW679769 (casopitant) to ZOF...
Location
GSK Investigational Site
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
PHASE2This study is designed to find the optimal (best) doses of GW679769 that co...
Location
GSK Investigational Site
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
PHASE2This study is designed to determine whether morning doses of GW679769, take...
Location
GSK Investigational Site
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
PHASE3This study is being conducted to see if adding GW679769 (casopitant) to ZOF...
Location
GSK Investigational Site